<style face="normal" font="default" size="100%">Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial</style>

Drupal-Bibcite